Developing CAR-T Cell Therapies for the Future

被引：0
|
作者：
Thomas, Felicity
机构：
来源：
BIOPHARM INTERNATIONAL | 2024年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [21] CAR-T cell therapy A look into the (possible) future
    Freye, Reimund
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (05)
  • [22] Clinical evidence of immunogenicity of CAR-T cell therapies and its implication in the clinical development of CAR-T drug products
    Alfar, Hammodah R.
    Chen, Cecil
    Lachacz, Eric
    Tang, Weifeng
    Zhang, Yuqian
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [23] Effectiveness and comparison of CAR-T cell therapies for synovial sarcoma; HER2-targeted CAR-T and NKG2D-based CAR-T
    Miyazaki, Tomohiro
    Imai, Chihaya
    Oike, Naoki
    Murayama, Yudai
    Ariizumi, Takashi
    Baba, Minori
    Kasahara, Yasushi
    Kawashima, Hiroyuki
    CANCER RESEARCH, 2024, 84 (06)
  • [24] Advancing autoimmune Rheumatic disease treatment: CAR-T Cell Therapies - Evidence, Safety, and future directions
    Ohno, Ryunosuke
    Nakamura, Akihiro
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 67
  • [25] Nanoporous Substrates to Advance CAR-T Cell Production for Advanced Cell Therapies
    Zund, Tamara
    Lickert, Sebastian
    Strebel, Anja
    Murner, Marcia
    Willms, Tido
    Simsek, Hasan
    Du, Weijie
    Wagner, Dimitrios Laurin
    Vogel, Viola
    Klotzsch, Enrico
    BLOOD, 2023, 142
  • [26] Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
    Shah, Nirav N.
    Maatman, Theresa
    Hari, Parameswaran
    Johnson, Bryon
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [27] Side effect management: checkpoint inhibitors and CAR-T cell therapies
    Brockelmann, P. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (SUPPL 3) : 11 - 11
  • [28] WILL CAR-T CELL THERAPIES CHANGE HOW DRUGS ARE PRICED AND REIMBURSED?
    Macaulay, R.
    Kasli, I
    VALUE IN HEALTH, 2019, 22 : S92 - S93
  • [29] An Automated Manufacturing Solution for Patient Specific CAR-T Cell Therapies
    O'Connor, Joseph William
    Dutta, Debargh
    Daita, Kalyani
    Abraham, Eytan
    Shi, Yaling
    MOLECULAR THERAPY, 2019, 27 (04) : 88 - 88
  • [30] WILL CAR-T CELL THERAPIES CHANGE HOW DRUGS ARE PRICED AND REIMBURSED?
    Macaulay, R.
    Kasli, I
    VALUE IN HEALTH, 2019, 22 : S430 - S430
12345